Sign Out
Inform the physician or pharmacist if the patient is taking or have recently taken any other medicines including medicines obtained without a prescription.
If the patient is taking an oral anticoagulant or any other drug that affects coagulation [eg, acetylsalicylic acid or nonsteroidal anti-inflammatory drugs (NSAIDs)] (see Precautions).
Increased bleeding time has been seen when Omacor is given in conjunction with acetylsalicylic acid and warfarin, but without haemorrhagic complications (see Precautions).
Acetylsalicylic Acid: Patients should be informed about potential increased bleeding time.
Warfarin and Coumarin: The prothrombin time/international normalized ratio (PT/INR) must be monitored during combination treatment with Omacor among patients receiving blood-thinning therapy, and when treatment with Omacor is discontinued.
